Vanda Pharmaceuticals (VNDA) Applications for HETLIOZ Accepted by FDA for Priority Review
Go back to Vanda Pharmaceuticals (VNDA) Applications for HETLIOZ Accepted by FDA for Priority Review| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 6.03 +0.03 (0.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.00 | 52 Week High | $18.00 | |||
| Open | $5.97 | 52 Week Low | $6.91 | |||
| Day High | $6.11 | P/E | N/A | |||
| Day Low | $5.96 | EPS | $-0.67 | |||
| Volume | 205,241 | |||||
